EUCTR2019-001336-62-DK
Active, not recruiting
Phase 1
Anticoagulation for Stroke Prevention In patients with Recent Episodes of perioperative Atrial Fibrillation after noncardiac surgery - The ASPIRE-AF trial - The ASPIRE-AF trial
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Hamilton Health Sciences Corporation
- Enrollment
- 2800
- Status
- Active, not recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients are eligible if they fulfill all of the following criteria:
- •1\. have had noncardiac surgery with at least an overnight hospital admission after surgery in the last 35 days;
- •2\. have had \= one episode of clinically important perioperative AF during or after their surgery;
- •3\. are in sinus rhythm at the time of randomization;
- •4\. meet any of the following high\-risk criteria; and
- •o age 55\-74 years, and having either known cardiovascular disease, recent major vascular surgery, or a CHA2DS2VASc score \= 3; or
- •o age \= 75 years.
- •5\. provide written informed consent to participate
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
Exclusion Criteria
- •Patients are excluded if they meet any of the following criteria:
- •1\. have a history of documented AF prior to noncardiac surgery; a history of subclinical AF only (i.e., AF episodes only documented by pacemakers or similar devices) or a previous history of perioperative AF only (after cardiac or noncardiac surgery) are not exclusion criteria;
- •2\. need for long\-term systemic anticoagulation (e.g., pre\-existing AF, mechanical heart valve);
- •3\. have an ongoing need for long\-term dual antiplatelet treatment;
- •4\. have a contraindication to oral anticoagulation;
- •5\. have severe renal insufficiency (eGFR \< 30 ml/min);
- •6\. have had an acute stroke in the past three months;
- •6\. have had cardiac surgery in the past three months;
- •7\. have a history of nontraumatic intracranial, intraocular, or spinal bleeding;
- •8\. have hemorrhagic disorder or bleeding diathesis;
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 4
Multinational, investigator-initiated study of oral anticoagulation versus no anticoagulation for the prevention of stroke and other adverse cardiovascular events in patients with transient perioperative atrial fibrillation after noncardiac surgery and additional stroke risk factors.Health Condition 1: I48- Atrial fibrillation and flutterHealth Condition 2: I63- Cerebral infarctionCTRI/2023/01/049006Population Health Research Institute
Active, not recruiting
Phase 1
Anticoagulation for Stroke Prevention In patients with Recent Episodes of perioperative Atrial Fibrillation after noncardiac surgeryPerioperative atrial fibrillation after noncardiac surgeryMedDRA version: 20.0Level: LLTClassification code: 10005103Term: Bleeding Class: 10047065MedDRA version: 20.0Level: LLTClassification code: 10003663Term: Atrial flutter/ fibrillation Class: 10007541MedDRA version: 26.1Level: LLTClassification code: 10042244Term: Stroke Class: 10029205Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]CTIS2023-509142-35-00Hamilton Health Sciences Corporation2,270
Active, not recruiting
Phase 1
Anticoagulation for Stroke Prevention In patients with Recent Episodes of perioperative Atrial Fibrillation after noncardiac surgery - The ASPIRE-AF trialEUCTR2019-001336-62-ITPopulation Health Research Institute2,800
Active, not recruiting
Phase 1
Anticoagulation for Stroke Prevention In patients with Recent Episodes of perioperative Atrial Fibrillation after noncardiac surgeryPerioperative atrial fibrillation after noncardiac surgeryMedDRA version: 22.1Level: LLTClassification code 10042244Term: StrokeSystem Organ Class: 100000004852MedDRA version: 20.0Level: LLTClassification code 10005103Term: BleedingSystem Organ Class: 100000004866MedDRA version: 20.0Level: LLTClassification code 10003663Term: Atrial flutter/ fibrillationSystem Organ Class: 100000004849Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]EUCTR2019-001336-62-NLPopulation Health Research Institute2,800
Recruiting
Not Applicable
Pre-stroke awareness and antithrombotic use for atrial fibrillation in patients with acute ischemic stroke - Data from a multicenter hospital-based registryDiseases of the nervous systemKCT0000851Seoul National University Bundang Hospital3,145